Status: Not yet recruiting
An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers
This study was a single-center, randomized, open-label, two-agent, two-cycle, double-cross bioequivalence trial.
Participants needed: 40
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Frontier Biotechnologies Inc.Updated: Jul 19, 2024
Eligibility criteria
Male weight ≥50 kg, female weight ≥45 kg, body mass index (BMI) between 19.0 and... [+2]
Participated in other drug intervention studies within 90 days [+17]